U.S. News & World Report Names Ornish Lifestyle Medicine

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
108
U.S. News & World Report Names Ornish Lifestyle Medicine “Best Heart-Healthy Diet” for Seventh Year in a Row

ATLANTA, Jan. 04, 2017 (GLOBE NEWSWIRE) -- U.S. News & World Report has awarded the Ornish Lifestyle Medicine Diet the No. 1 ranking for the Best Heart-Healthy Diet for the seventh year in a row, every year since the publication’s rankings began. The Ornish Lifestyle Medicine™ program – now part of Sharecare through its 2016 acquisition of Healthways – is supported by nearly 40 years of rigorous clinical studies by Dean Ornish, M.D. and colleagues, and addresses the root causes of heart disease by using lifestyle changes as a less invasive and more effective treatment option than drugs or surgery.

The U.S. News rankings are determined by a panel of nationally recognized health experts in diet, nutrition, obesity, food psychology, diabetes and heart disease. The experts reviewed information on 38 diet plans, scoring each in nine categories: overall, weight-loss, fast weight loss, easiest to follow, diabetes, healthy eating, heart disease, and plant-based. In addition to the No. 1 heart healthy diet ranking, the Ornish diet ranked third for Best Plant-Based Diet and fourth for Best Diabetes Diet .

Dr. Ornish’s whole foods plant-based nutrition plan is naturally low in both fat and refined carbohydrates; and is only one of four equally important components of his transformational Ornish Lifestyle Medicine program, which remains the number one Intensive Cardiac Rehabilitation program in the country.

“My colleagues and I are honored to be recognized by U.S. News for the seventh year running, and appreciate their commitment to helping people understand that comprehensive lifestyle changes can not only prevent but also reverse the progression of heart disease, as well as enable people to reduce or discontinue medications for lowering blood pressure and cholesterol levels,” said Dr. Ornish. “While the science is complex, our application of it is both straightforward and practical: eat well, stress less, move more, and love more; and the more closely people follow our program, the more they improve.”   

Since 2013, Dr. Ornish has partnered with Healthways, a Sharecare company, to deliver this nationally-renowned comprehensive heart disease reversal program to patients through health systems, hospitals and physician groups. With 25 sites around the country, this revolutionary program is reimbursed by Medicare and many major insurance companies for clinically eligible individuals . These partnerships demonstrate the shared vision of Sharecare, Dr. Ornish and providers to help people live healthier and more fulfilling lives, going beyond physical health to improve overall well-being.

About Ornish Lifestyle Medicine ™ The first and only program that is scientifically proven to reverse the progression of heart disease. Ornish Lifestyle Medicine has spread across the country and begun to revolutionize the way that Americans treat heart disease. Today, the program is reimbursed by Medicare and many other commercial payers, offered in more than 14 states, and delivered with a turnkey process that is optimized by years of operating knowledge. Most importantly, since 2014 alone, it has helped thousands of people from across the country take back their lives. For more information, visit https://www.ornish.com/ .

About Sharecare Sharecare is the digital health company that helps people manage all their health in one place. The Sharecare platform provides each person – no matter where they are in their health journey – with a comprehensive and personalized health profile, where they can dynamically and easily connect to the information, evidence-based programs and health professionals they need to live their healthiest, happiest and most productive life. With award-winning and innovative frictionless technologies, scientifically validated clinical protocols and best-in-class coaching tools, Sharecare helps providers, employers and health plans effectively scale outcomes-based health and wellness solutions across their entire populations. To learn more, visit www.sharecare.com .

Contact: Joli Studley-Cibik 412-580-8528 Joli.Studley@healthways.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 288

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 343

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 451

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 295

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 289

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Addressing the Housing Crisis: Federal Funding Efforts

Updated Category News Views 313

Tackling Canada's Housing Crisis Canada is actively working to combat its housing crisis, with significant measures aimed at helping those who are homeless. While there’s a sense of hope in the air, the presence of encampments underscores the immediate need for long-lasting solutions. The federal government is stepping up its efforts, showing a dedicated resolve to...

Continue Reading
Rigetti Computing Readies for Third Quarter Results Announcement

Updated Category News Views 65

Rigetti Computing Announces Third Quarter Financial Results Rigetti Computing, Inc. (Nasdaq: RGTI), recognized as a leader in hybrid quantum-classical computing, has exciting news regarding its financial performance. The company is set to release its financial results for the third quarter of 2024 on a specified date, marking an important moment for stakeholders and...

Continue Reading
Novartis Reports Outstanding Q3 Performance and 2025 Outlook

Updated Category News Views 545

Solid Q3 Performance by Novartis In a significant announcement, Novartis reported an impressive growth in net sales and core operating income for the third quarter. During this period, the company's net sales reached USD 13.9 billion, reflecting a growth of 7% on a constant currency basis and an 8% increase in USD terms. Core operating income showed a similar trajectory,...

Continue Reading
Forestar Group Inc. Set to Announce First Quarter Earnings Soon

Updated Category News Views 134

Forestar Group Inc. to Announce First Quarter Earnings Forestar Group Inc. (NYSE: FOR) is preparing to share key financial results for its first quarter, marking the end of December 2024. This eagerly awaited announcement will take place shortly before the markets open on the designated day. Shareholders and interested parties will have the opportunity to hear about the...

Continue Reading
ImCheck Therapeutics Secures EMA Orphan Drug Designation

Updated Category News Views 196

ImCheck Therapeutics Secures EMA Orphan Drug Designation ImCheck Therapeutics has exciting news as it recently announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to ICT01, its flagship treatment aimed at addressing acute myeloid leukemia (AML). This development, coming shortly after a similar designation from the U.S. FDA,...

Continue Reading